QuintilesIMS Institute Archives - CDR

Spike in new medicines to lift global drug spending

December 6, 2016 by Chain Drug Review global drug spending, Murray Aitken, Outlook for Global Medicines Through 2021: Balancing Cost and Value, QuintilesIMS Institute, worldwide spending on medicines Leading Headlines, Pharmacy, Retail News

DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Though annual growth stands to moderate, global drug spending will climb to an estimated $1.5 trillion by 2021, up 33% from this year, according to the QuintilesIMS Institute. Worldwide spending on medicines is projected to grow at a 4% to 7% compound annual rate over the next

Savings from generic drugs edge up

October 19, 2016 by Chain Drug Review Chip Davis, generic drugs, Generic Pharmaceutical Association, generic prescription drugs, GPhA, GPhA's 2016 Generic Drug Savings and Access in the United States report, health care spending, QuintilesIMS Institute, U.S. drug spending Leading Headlines, Pharmacy, Retail News

WASHINGTON — Annual health care savings from generic prescription drugs rose nearly 10% last year to $227 billion, according to the Generic Pharmaceutical Association (GPhA). GPhA’s 2016 Generic Drug Savings and Access in the United States report, released Wednesday, tallied the 10-year national savings for generics at $1.46 trillion, representing a gain of 328% from